Median Diagnostics Inc. (XKON:233250)
8,890.00
+90.00 (1.02%)
At close: Apr 28, 2026
Median Diagnostics Market Cap
Median Diagnostics has a market cap or net worth of 15.53 billion as of April 29, 2026. Its market cap has decreased by -38.69% in one year.
Market Cap
15.53B
Enterprise Value
n/a
Revenue
7.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,890.00
Market Cap Chart
Since June 26, 2017, Median Diagnostics's market cap has decreased from 22.09B to 15.53B, a decrease of -29.72%. That is a compound annual growth rate of -3.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeopleBio | 34.89B |
| AItheNutrigene | 6.13B |
| GeneMatrix | 42.42B |
| Seoulin Bioscience | 57.20B |
| Protia | 63.36B |
| Green Cross Medical Science | 85.23B |
| HLB Panagene | 99.35B |
| Cytogen | 128.73B |